ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,121.20
0.00%
Dow Jones
39,331.85
0.41%
Gold vs US Dollar
2,340.91
0.46%
Brent Oil
86.50
0.06%
Bitcoin
60,929.28
-1.77%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Apyx Medical Corporation (APYX)

  7. Apyx Medical Corporation (APYX) News

Apyx Medical (APYX)

Apyx Medical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APYX
DateTimeSourceHeadlineSymbolCompany
26/06/202412:30PR Newswire (US)Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental HealthNASDAQ:APYXApyx Medical Corporation
31/05/202419:49Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:APYXApyx Medical Corporation
09/05/202417:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APYXApyx Medical Corporation
09/05/202415:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
09/05/202412:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APYXApyx Medical Corporation
09/05/202412:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
09/05/202412:05Business WireApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
09/05/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
09/05/202412:00Business WireApyx Medical Corporation Announces Board Leadership TransitionNASDAQ:APYXApyx Medical Corporation
25/04/202412:30Business WireApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:APYXApyx Medical Corporation
11/04/202412:30Business WireApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitNASDAQ:APYXApyx Medical Corporation
21/03/202411:00Business WireApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
04/03/202412:30Business WireApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024NASDAQ:APYXApyx Medical Corporation
21/02/202412:33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
21/02/202412:30Business WireApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingNASDAQ:APYXApyx Medical Corporation
14/02/202422:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
14/02/202420:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
14/02/202412:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
13/02/202415:58Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
07/02/202423:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
02/02/202416:56Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
23/01/202414:52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APYXApyx Medical Corporation
23/01/202414:49Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
22/01/202413:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
22/01/202412:30Business WireApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyNASDAQ:APYXApyx Medical Corporation
11/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
11/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
11/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
11/01/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
08/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:APYX

Your Recent History

TSXV
NFC
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved